We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
+19.99%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96.3M
AUM Growth
+$11.2M
Cap. Flow
-$150K
Cap. Flow %
-0.16%
Top 10 Hldgs %
54.39%
Holding
61
New
6
Increased
24
Reduced
18
Closed
8

Top Buys

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$5.53M
2
SAGE
Sage Therapeutics
SAGE
+$4.33M
3
EFOR
Everforth Inc
EFOR
+$1.66M
4
ABCB icon
Ameris Bancorp
ABCB
+$1.64M
5
ABM icon
ABM Industries
ABM
+$1.45M

Top Sells

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$3.05M
2
PFPT
Proofpoint, Inc.
PFPT
+$3.01M
3
ARRY
Array Biopharma Inc
ARRY
+$2.33M
4
IMMU
Immunomedics Inc
IMMU
+$2.33M
5
GVA icon
Granite Construction
GVA
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 22.35%
2 Industrials 19.7%
3 Financials 17.34%
4 Technology 9.34%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSMT icon
26
Pricesmart
PSMT
$5.94B
$921K 0.96%
15,667
+8,117
+108% +$507K
SYNH
27
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$905K 0.94%
17,479
-6,372
-27% -$309K
QTS
28
DELISTED
QTS REALTY TRUST, INC.
QTS
$904K 0.94%
20,115
-457
-2% -$19.1K
PRAH
29
DELISTED
PRA Health Sciences, Inc.
PRAH
$865K 0.9%
7,844
+4,488
+134% +$469K
ARRY
30
DELISTED
Array Biopharma Inc
ARRY
$854K 0.89%
35,044
-111,908
-76% -$2.33M
ADSW
31
DELISTED
Advanced Disposal Services Inc
ADSW
$809K 0.84%
28,909
+5,000
+21% +$130K
ALGT icon
32
Allegiant Air
ALGT
$2.67B
$804K 0.84%
6,204
+3,096
+100% +$394K
KNX icon
33
Knight Transportation
KNX
$11.4B
$770K 0.8%
23,527
+7,193
+44% +$229K
WWD icon
34
Woodward
WWD
$24B
$724K 0.75%
7,637
– –
MMS icon
35
Maximus
MMS
$3.33B
$701K 0.73%
9,854
+2,235
+29% +$157K
AVNT icon
36
Avient
AVNT
$3.34B
$614K 0.64%
20,907
+11,331
+118% +$356K
ZD icon
37
Ziff Davis
ZD
$2.01B
$596K 0.62%
7,926
+837
+12% +$57.8K
AXSM icon
38
Axsome Therapeutics
AXSM
$11.8B
$568K 0.59%
+39,921
New +$371K
MDSO
39
DELISTED
Medidata Solutions, Inc.
MDSO
$556K 0.58%
7,581
+2,090
+38% +$151K
KYNB
40
Kyntra Bio
KYNB
$28.1M
$453K 0.47%
333
+122
+58% +$165K
TEN
41
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$444K 0.46%
19,996
+7,770
+64% +$245K
BLD
42
DELISTED
TopBuild
BLD
$443K 0.46%
6,855
-19,708
-74% -$1.11M
BCO icon
43
Brink's
BCO
$5.06B
$410K 0.43%
5,448
+37
+0.7% +$2.75K
BPMC
44
DELISTED
Blueprint Medicines
BPMC
$395K 0.41%
4,924
-1
-0% -$74
EME icon
45
Emcor
EME
$30.4B
$351K 0.36%
4,806
– –
FOLD
46
DELISTED
Amicus Therapeutics
FOLD
$345K 0.36%
25,357
+3,772
+17% +$46.1K
LPX icon
47
Louisiana-Pacific
LPX
$5.33B
$321K 0.33%
+13,192
New +$322K
RARE icon
48
Ultragenyx Pharmaceutical
RARE
$2.51B
$319K 0.33%
+4,582
New +$262K
CBLK
49
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$310K 0.32%
22,241
– –
SRPT icon
50
Sarepta Therapeutics
SRPT
$1.67B
$290K 0.3%
2,421
-99
-4% -$12.7K
1
2
3

Similar funds

CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
QI
Quilter Investors London, United Kingdom $22.3M AUM 6.63% 1-Year Est. Return
HWM
Highwater Wealth Management Glendale, Colorado $22.6M AUM 3.46% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
MAU
MRA Associates USA Phoenix, Arizona $25.4M AUM 0.38% 1-Year Est. Return
FCG
FrontFour Capital Group Greenwich, Connecticut $26.5M AUM 17.69% 1-Year Est. Return

Pacific View Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Pacific View Asset Management held 61 positions worth $96.3M, up 13% from $85.1M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Pacific View Asset Management's Q1 2019 filing shows 6 new, 24 increased, 18 reduced and 8 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 50,601 shares worth $5.66M. The largest sale was Loxo Oncology, Inc, an estimated $3.05M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 14% a quarter earlier, followed by Industrials and Financials.

  • Pacific View Asset Management's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 50,601 shares worth $5.66M.
  • Pacific View Asset Management added most to Sage Therapeutics in Q1 2019, an estimated $4.33M increase.
  • Pacific View Asset Management's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $2.33M.
  • Pacific View Asset Management fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $3.05M.
  • Pacific View Asset Management's ten largest holdings make up 54% of its $96.3M portfolio in Q1 2019.
  • Pacific View Asset Management opened 6 new positions and closed 8 in Q1 2019.
  • Pacific View Asset Management's portfolio value rose 13% quarter-over-quarter to $96.3M.

Based on Pacific View Asset Management's 13F filing for Q1 2019, filed 15 May 2019.